Ziminor-NT Tablet contains a combination of Gabapentin 400mg and Nortriptyline 10mg, formulated for the management of neuropathic pain and certain types of chronic pain disorders. Gabapentin, an anticonvulsant, acts by modulating calcium channels in the central nervous system, thereby reducing neuronal excitability and alleviating neuropathic pain symptoms. Nortriptyline, a tricyclic antidepressant, enhances noradrenergic and serotonergic neurotransmission by inhibiting the reuptake of these neurotransmitters, contributing to its analgesic and mood-stabilizing effects. The synergistic action of these two agents provides effective pain relief, particularly in conditions such as diabetic neuropathy, postherpetic neuralgia, and fibromyalgia. Ziminor-NT is indicated for patients who require both neuropathic pain control and adjunctive antidepressant therapy. It should be used under medical supervision, with dosage adjustments based on clinical response and tolerability. Common adverse effects may include dizziness, somnolence, dry mouth, and gastrointestinal disturbances. Caution is advised in patients with renal impairment, cardiovascular disease, or a history of seizures. Ziminor-NT Tablet should not be discontinued abruptly to avoid withdrawal symptoms. This combination therapy offers a comprehensive approach to managing complex pain syndromes, improving patient quality of life.